Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,608 | -27,308 | -11,997 | -7,183 | N/A |
| Depreciation Amortization | -605 | 2 | 2 | 2 | N/A |
| Accounts payable and accrued liabilities | 3,971 | -150 | 849 | 193 | N/A |
| Other Working Capital | 6,551 | -4,248 | 933 | -179 | N/A |
| Other Operating Activity | 7,746 | 4,511 | 5,361 | 2,360 | 0 |
| Operating Cash Flow | $-32,945 | $-27,193 | $-4,852 | $-4,807 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -116,839 | N/A | N/A | N/A | N/A |
| PPE Investments | -455 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-117,294 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 182 | 167,637 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 96,140 | 11,992 | 2,993 | 0 |
| Financing Cash Flow | $182 | $263,777 | $11,992 | $2,993 | $N/A |
| Beginning Cash Position | 245,041 | 8,457 | 1,317 | 3,131 | N/A |
| End Cash Position | 94,984 | 245,041 | 8,457 | 1,317 | N/A |
| Net Cash Flow | $-150,057 | $236,584 | $7,140 | $-1,814 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,945 | -27,193 | -4,852 | -4,807 | N/A |
| Capital Expenditure | -455 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -33,400 | -27,193 | -4,852 | -4,807 | 0 |